Sarcoma Cancers News Articles | Treatment & Drug Studies

Skin Cancer News


Skin Cancer News

FDA_drug approval

Keytruda Approved for the Adjuvant Treatment of Patients With Stage III Melanoma

Merck announced that the Food and Drug Administration (FDA) has approved Keytruda(pembrolizumab) for the adjuvant treatment of patients with melanoma with involvement of lymph node(s) following complete resection. This marks the first approval for Keytruda in the adjuvant setting and the fourth approval for its use in skin cancers.  The approval was supported by data from the phase 3,…
FDA_accelerated approval

Keytruda Gains Merkel Cell Carcinoma Indication

The Food and Drug Administration has granted accelerated approval to Keytruda (pembrolizumab; Merck) for the treatment of patients with recurrent locally advanced or metastatic Merkel cell carcinoma.
Next hm-section-front in Sarcoma News